Kawasaki disease (KD) is an acute, febrile, and systemic vasculitis with unknown etiology while special infections and super-antigens are considered to have roles in disease development (
1,
2). Its prevalence in Asian countries was estimated as 239 cases per 100000 children less than five years old (
3,
4).
High grade fever, rash, redness of the lips and a typical strawberry tongue, cervical lymph node enlargement, and swelling over the hands/feet are common presentations of the disease (
5,
6). One of the most common complications of KD is cardiac complications, which is present with coronary artery disease, myocarditis, and pericarditis (
2). Coronary artery disease remains as the most prevalent cardiac complication presenting in one fourth of untreated children (
7,
8).
Administration of intravenous immunoglobulin (IVIG) during the first 10 days after symptoms detection will result in lower coronary artery aneurysm between 10% - 21% of cases could show drug resistance (
9,
10).